It is with deep pride and heartfelt gratitude that I share exciting news! Case Comprehensive Cancer Center (Case CCC) has received notice of award (NOA) from the National Cancer Institute (NCI) renewing our Cancer Center Support Grant (CCSG). The $25.5 million commitment reaffirms our standing as one of the nation's premier comprehensive cancer centers and is a direct reflection of your work. Each of you—researchers, clinicians, trainees, staff, and institutional partners—contributed to this achievement through science, collaboration, leadership, and support.
As many of you know, this is far more than a financial award—it is a powerful endorsement of the center’s scientific excellence, consortium model, and public impact. The merit score places us in the top 4.1% of all comprehensive cancer centers, a distinction that speaks to the strength of our programs, the rigor of our infrastructure, and the caliber of our people.
The grant ensures that we can continue to provide the scientific leadership, technology platforms, and training programs that have made Case CCC a vibrant and collaborative engine for discovery. It allows us to build on the strengths of our partners—Case Western Reserve University, University Hospitals, and Cleveland Clinic—and deliver meaningful advances for the 4 million people in our catchment area and beyond. Indeed, it is a shared achievement made possible by collaboration, commitment, and a 38-year mission to serve.
The only thing better than receiving good news is sharing it with those who helped make it possible. So I reiterate: These achievements belong to you. They are the result of years of consistent effort, strategic focus, and shared commitment to excellence. I hope you’ll take a moment to reflect on the role you’ve played in this success—whether in your lab, clinic, classroom, or office—and take pride in what we’ve accomplished.
Thank you for your partnership and belief in the power of this work. Together, we move forward with purpose and a renewed commitment to changing the future of cancer.
Gary K. Schwartz, MD, FASCO
Director, Case Comprehensive Cancer Center